Ibrutinib continues to influence the therapeutic landscape of chronic lymphocytic leukemia: new data presented at ASCO 2017
Crossref DOI link: https://doi.org/10.1186/s12916-017-0920-7
Published Online: 2017-08-16
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Molica, Stefano